A Randomized Trial of Unruptured Brain Arteriovenous Malformation (ARUBA) |
|
Cardiovascular Disease |
|
|
Actelion - AC-065A304 Multicenter, open-label, single-group study to assess the tolerability and the safety of the TRANSITion from inhaled tresprostinil to oral selexipag in patients with pulmonary arterial hypertension 20150803 |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Acute Cardiopulmonary Effects of Controlled Exposure to Wood Smoke |
|
Cardiovascular Disease, Chronic Respiratory Disease, Occupational and Environmental Disease |
|
|
Adapting of the Coronary Heart Disease Policy Model to U.S. Subpopulations |
Kirsten Bibbins-Domingo, MD, PhD |
Cardiovascular Disease |
|
|
Addressing Disparities in Chronic Disease with a Teen and Young Adult Focus |
Kirsten Bibbins-Domingo, MD, PhD |
Cardiovascular Disease, Diabetes |
|
|
Addressing Disparities in Chronic Disease with a Teen and Young Adult Focus |
Kirsten Bibbins-Domingo, MD, PhD |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Diabetes, Diet, Exercise, and Obesity |
|
|
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Advancing Sugary Beverage Reforms Through the Private Sector (Toolkit) |
Laura Schmidt, PhD |
Cardiovascular Disease, Diet, Exercise, and Obesity, Health Systems Strengthening |
|
|
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) |
Diane Havlir, MD |
HIV/AIDS, Cardiovascular Disease |
|
|
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study |
Diane Havlir, MD |
HIV/AIDS, Cardiovascular Disease |
|
|
An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (PRADAXA) |
|
Cardiovascular Disease |
|
|
Angiogenesis in Moving Cardiac Tissue: Influence of Motion on Endothelial Pattern Formation and Gene Expression |
|
Cardiovascular Disease |
|
|
Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack in U.S. Community Hospitals |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Association of Occupational Noise Exposure with Cardiovascular Diseases among Career Firefighters |
|
Cardiovascular Disease, Occupational and Environmental Disease |
|
|
Barber-Pharmacist Coordination to Improve Bldd Pressure Management in Black Men |
Kirsten Bibbins-Domingo, MD, PhD |
Cardiovascular Disease |
|
|
Body Surfacing Mapping to Guide Resynchronization Therapy for Congestive Heart Failure |
|
Cardiovascular Disease |
|
|
Bone Marrow Cell Therapy for Cardiac Disease: Impact of Donor Age and Infarction |
|
Cardiovascular Disease |
|
|
Bring it Down San Francisco: Harnessing cloud-based technology to improve hypertension management in a low-income underserved population |
Valy Fontil, MD, MAS, MPH |
Cardiovascular Disease, Engagement in Care, Treatment Adherence |
|
|
California Acute Stroke Prototype Registry (CASPR) / Development of Prototypes for the Paul Coverdell National Acute Stroke Registry |
|
Cardiovascular Disease |
|
|
Cardiac Regeneration Through Growth Factor Eluting Microrod Scaffolds |
Tejal Desai, PhD |
Cardiovascular Disease |
|
|
Cardiovascular Inflammation Reduction Trial (CIRT) |
|
Cardiovascular Disease |
|
|
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment |
Peter Hunt, MD |
HIV/AIDS, Cardiovascular Disease, Chronic Respiratory Disease, Aging |
|
|
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment |
Peter Hunt, MD |
HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging |
|
|
CASTIA Neurological Core Imaging Lab (NCIL) |
|
Cardiovascular Disease, Pharmacology and Drug Treatment, Neurology and Mental Health |
|
|
Childhood SES Factors: Impact on age-related cognitive and vascular health |
Maria Glymour, ScD, MS |
Cardiovascular Disease |
|
|
Closed-Chest Cell Injections into Mouse Mycardium Targeted by Ultrasound |
|
Cardiovascular Disease |
|
|
Cognitive Function, Alzheimer's Disease and Related Disorders in the HAALSI Cohort |
Maria Glymour, ScD, MS |
Cardiovascular Disease, Dementia and Cognitive Impairment |
|
|
Controlled Thirdhand Smoke Exposure Core |
|
Cardiovascular Disease, Chronic Respiratory Disease, Occupational and Environmental Disease |
|
|
Development of Human mAbs to Target Cardiomyocytes and Cardiac Fibroblasts |
|
Cardiovascular Disease, Immunology |
|
|
DIADS Project 2: Racial Disparities in Ischemic Stroke and Atherosclerotic Risk Factors in the Young |
Heather Fullerton, MD |
Cardiovascular Disease, Neurology and Mental Health |
|
|
Discrimination and biomarkers of cardiometabolic risk |
Thu Nguyen, ScD, MSPH |
Cardiovascular Disease |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Ectopic fat and atherosclerosis in South Asians |
Alka Kanaya, MD |
Cardiovascular Disease |
|
|
Ectopic Fat and Atherosclerosis in South Asians |
Alka Kanaya, MD |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease |
|
|
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Effect of low dose methotrexate on endothelial function and inflammation in HIV |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Effect of low dose methotrexate on endothelial function and inflammation in HIV |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) |
|
HIV/AIDS, Cardiovascular Disease, Aging |
|
|
Effect of Pitavastatin on Kidney Function in HIV-infected Persons |
Diane Havlir, MD |
HIV/AIDS, Cardiovascular Disease |
|
|
Effects of Psychosocial Stress on Endothelial Progenitor Cells |
|
Cardiovascular Disease |
|
|
Endothelial Function and Glucose Tolerance in South Asians |
Alka Kanaya, MD |
Cardiovascular Disease, Diet, Exercise, and Obesity |
|
|
Endothelial Primary Cilia Protect Against Atherosclerosis |
Jeremy Reiter, MD, PhD |
Cardiovascular Disease |
|
|
Enhancing Mexican Capacity for Cardiovascular Disease (CVD) Policy Research |
Kirsten Bibbins-Domingo, MD, PhD |
Cardiovascular Disease, Training and Capacity Building |
|
|
Enhancing Mexican Capacity for Cardiovascular Policy Research |
Kirsten Bibbins-Domingo, MD, PhD |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Health Economics and Effectiveness |
|
|
Enhancing Mexican Capacity for CVD Policy Research |
Alicia Fernandez, MD |
Cardiovascular Disease |
|
|
ENSURE in AF: Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Parallel Group Study Comparing Edoxaban with Enoxaparin/Warfarin Followed by Warfarin Alone in Subjects Undergoing Planned electrical cardioversion of nonvalvular atrial fibrillat |
|
Cardiovascular Disease |
|
|
Epi4K: Gene discovery in 4,000 Epilepsy Genomes (4/7) |
Elliott Sherr, MD, PhD |
Cardiovascular Disease, Genetics |
|
|
Epidemiology of stroke |
Anthony Kim, MD |
Cardiovascular Disease, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
Estrogen Receptor Variance and CHD Risk in HERS |
Eric Vittinghoff, PhD |
Cardiovascular Disease |
|
|
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) |
|
Cardiovascular Disease, Neurology and Mental Health |
|
|
Evaluating Perceptions of Cardiovascular Disease Risk and Prevention: A Qualitative Study in an UnderResourced Setting in Rural South India |
Joan Chang, MS |
Cardiovascular Disease |
|
|
Evaluation of Harmful Effects of Cannabis Smoke on Vascular Endothelial Function |
|
Cardiovascular Disease, Occupational and Environmental Disease, Smoking and Tobacco |
|
|
Failure Time Methods for Family Disease Studies |
David Glidden, PhD |
Cardiovascular Disease |
|
|
Genetic and molecular pathophysiology of ATS |
Louis Ptacek, MD |
Cardiovascular Disease, Genetics |
|
|
Guideline development for rheumatic heart disease and endocarditis |
Ann Bolger, MD |
Cardiovascular Disease, Systematic Reviews and Guideline Development |
|
|
Heart Truth Asian & Pacific Islander Community Partnership Initiative |
|
Cardiovascular Disease |
|
|
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Hypertension Treatment Adherence in a Low-Income Tribal Region of Rural Southern India. A Qualitative Study |
Kaylan Agnew, MS |
Cardiovascular Disease |
|
|
Image-Based Numerical Predictions of Hemodynamics following Vascular Intervention |
David Saloner, PhD |
Cardiovascular Disease, Drug and Diagnostics Development, Neurology and Mental Health |
|
|
Impact of a novel multicomponent nutrition intervention on cardiovascular disease risk factors among food-insecure adults with HIV in the Dominican Republic |
Kartika Palar, PhD |
Cardiovascular Disease, Malnutrition, Micronutrients, Food Insecurity |
|
|
Impact of Flavanols on Vascular Reactivity and Cardiac Function in Rodents Measured with High Resolution Ultrasound |
|
Cardiovascular Disease |
|
|
Impact of Health Literacy Interventions on Outcome of Patients with Diabetes and Hypertension in Latin America and the Caribbean: A Systematic Review |
Lucia Abascal, MD, MS |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Diabetes |
|
|
Impact of Regionalization of Care in Acute Stroke Patients |
|
Cardiovascular Disease |
|
|
Implementation of Interventions to Improve the Uptake of Cardiovascular Disease Prevention Strategies in Sub-Saharan Africa: A Systematic Review and Meta-analysis |
Rah-Sha Al-Hassan, MS |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease |
|
|
In vivo diagnostics for cardiovascular disease |
Charles Craik, PhD |
Cardiovascular Disease |
|
|
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection |
|
HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Insulin Resistance Intervention after Stroke (IRIS) Trial |
|
Cardiovascular Disease, Diabetes |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
Lifecourse Cardiovascular Risk, Depression and Cognition in Black & White Adults |
Eric Vittinghoff, PhD |
Cardiovascular Disease |
|
|
MAPS: Matrix And Platinum Science, A Prospective, Randomized, Multicenter, Trial Investigating Matrix2 tm and GDC? Coils for the treatment of intracranial saccular aneurysms Trial |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Measuring Relative Cardiovascular Health Risks of Inhaled Tobacco Products |
|
Cardiovascular Disease, Smoking and Tobacco |
|
|
Mediators of Atherosclerosis in South Asians Living in America |
Alka Kanaya, MD |
Cardiovascular Disease, Immigration and Migration |
|
|
Medtronic - 2015 EP Fellowship 20141212 RB |
|
Cardiovascular Disease, Residencies, Fellowships, and Postdoctoral Training |
|
|
Mentoring patient-oriented research on the health consequences of polydrug use |
Elise Riley, PhD |
HIV/AIDS, Cardiovascular Disease, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Substance Abuse, Training and Capacity Building |
|
|
Metabolic Syndrome and Atherosclerosis in South Asians |
Alka Kanaya, MD |
Cardiovascular Disease, Diabetes |
|
|
Microrna Regulation of Cardiac Cell Polarity in Development and Disease |
|
Cardiovascular Disease |
|
|
Mindfulness-education intervention for atrial fibrillation symptom management |
Linda Ottoboni, RN, MS |
Cardiovascular Disease, Patient and Peer Education |
|
|
MitraClip China Trial CRD956 |
Atif N. Qasim, MD |
Cardiovascular Disease, Drug and Diagnostics Development |
|
|
Molecular Mechanism of Post-myocardial Infarction Cardiac Regeneration by Novel Therapeutic Peptides |
|
Cardiovascular Disease |
|
|
Myocardial Reconstruction for the Treatment of CHF |
|
Cardiovascular Disease |
|
|
Myocardial Reconstruction for the Treatment of Congestive Heart Failure (CHF) |
|
Cardiovascular Disease |
|
|
NAAccord (CHK-UP on HIV Supplement) |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease |
|
|
NCDs in India |
Reena Gupta, MD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity |
|
|
Neuroform Angiographic Analysis (Subset of MAPS study data) |
|
Cardiovascular Disease, Drug and Diagnostics Development |
|
|
NSA Guidelines |
|
Cardiovascular Disease, Systematic Reviews and Guideline Development |
|
|
Optimization of health care expenditures to maximize societal value |
Dhruv Kazi, MD, MSc, MS |
Cardiovascular Disease, Drug and Diagnostics Development, Health Economics and Effectiveness |
|
|
Optimizing Management of Transient Ischemic Attacks |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Outcomes Modeling for VA Return on Investment Analysis |
Kirsten Bibbins-Domingo, MD, PhD |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Diet, Exercise, and Obesity, Health Economics and Effectiveness |
|
|
Overcoming impairment of bone marrow cell therapy for myocardial infarction: Role of B cells |
|
Cardiovascular Disease |
|
|
Pacemarker & Beta-Blocker Therapy Post-Myocardial Infarct |
|
Cardiovascular Disease |
|
|
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT |
Valy Fontil, MD, MAS, MPH |
Cardiovascular Disease, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Perceived Discrimination, Stress Responses and Cardiovascular Regeneration among African Americans |
|
Cardiovascular Disease, Stigma and Discrimination |
|
|
Pharmacokinetics and Pharmacodynamics of Nicotine |
Neal Benowitz, MD |
Cardiovascular Disease, Smoking and Tobacco |
|
|
Phase III Clinical Trial "Platelet Oriented Inhibition in New Tia" - Drug: Plavix |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System (CF-EAS) for the Treatment of Symptomatic Atrial Fibrillation (ENABLE-AF) |
|
Cardiovascular Disease |
|
|
Predicting Stroke after Trauma (PSAT) |
Heather Fullerton, MD |
Cardiovascular Disease |
|
|
Predictors of Cardiomyopathy Progression in a Cohort of Bolivian Patients with Chagas Disease |
Caryn Bern, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Cardiovascular Disease |
|
|
Preventing Morbidity and Mortality and Heart Failure Among Persons with Chronic Renal Insufficiency |
Michael Shlipak, MD |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease |
|
|
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Protein Inhibitor of Galectin-3 to Limit Fibrosis after Myocardial Infarction |
|
Cardiovascular Disease |
|
|
Quality Improvement in Stroke Prevention (QUISP) |
|
Cardiovascular Disease, Neurology and Mental Health |
|
|
Randomized, Double-Blind Placebo-Controlled Phase 2a Study to Assess the Effect of CCR2 Antagonism by MLN1202 on Atherosclerotic Inflammation in Subjects with Stable Atherosclerotic Cardiovascular Disease Using FDG PET/CT Imaging |
|
Cardiovascular Disease |
|
|
Replace Registry |
|
Cardiovascular Disease |
|
|
Restorative Yoga for Therapy of the Metabolic Syndrome (RHYTHMS) Study |
Alka Kanaya, MD |
Cardiovascular Disease, Diabetes, Diet, Exercise, and Obesity |
|
|
Resynchronization Hemodynamic Treatment for Heart Failure Management Study (Rythm ICD) |
|
Cardiovascular Disease |
|
|
Role of Monocyte Oxidative Stress and Mineralocorticoid Receptor Signaling on Cardiovascular Disease and Persistent Inflammation in Antiretroviral-Treated HIV+ Persons |
|
HIV/AIDS, Cardiovascular Disease |
|
|
Safety of Sports for Patients with Implantable Cardioverter-Defibrillators: A Multicenter Registrry |
|
Cardiovascular Disease |
|
|
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes |
|
|
Social and Cultural Influences on cardiovascular risk factors in South Asians |
Alka Kanaya, MD |
Cardiovascular Disease |
|
|
SOCRATES - Acute Stroke Or Transient Ischaemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
St Jude Medical - 2015 Electrophysiology Fellowship 20150226 |
|
Cardiovascular Disease, Residencies, Fellowships, and Postdoctoral Training |
|
|
St. Jude EP Fellowship Program |
|
Cardiovascular Disease |
|
|
Stimulants and Childhood Stroke: a Population-Based Nested Case-Control Study |
Nancy Hills, PhD |
Cardiovascular Disease, Pediatrics |
|
|
Sustainable approaches to care delivery in Uganda |
Gabriel Chamie, MD |
HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diet, Exercise, and Obesity, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence |
|
|
Teleconsultation by Emergency Medical Services For Acute Stroke Recognition: Feasibility Study |
|
Cardiovascular Disease |
|
|
The cardiovascular impact of household air pollution in semi-urban and rural communities in Puno, Peru |
|
Cardiovascular Disease, Occupational and Environmental Disease |
|
|
The distribution and determinants of Non-communicable Diseases in informal settlements (slums) in Northeastern Brazil |
Alon Unger, MD |
Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Occupational and Environmental Disease |
|
|
The Impact of Cardiac Care Regionalization on Access, Treatment, and Outcomes |
Renee Hsia, MD |
Cardiovascular Disease, Access or Barriers to Care |
|
|
The Impact of Cardiac Care Regionalization on Access, Treatment, and Outcomes |
Renee Hsia, MD |
Cardiovascular Disease |
|
|
The Selective Marketing of Sugar-Sweetened Beverages (SSBs) to Children: An Analysis of Internal Industry Documents |
Laura Schmidt, PhD |
Cardiovascular Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Pediatrics |
|
|
Therapeutic Effects of Pharmacological Manipulation of Intracellular Nitric Oxide Levels in Cardiovascular Disease |
|
Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Thrombosis Gene Polymorphisms and Early CHD Risk in HERS |
Eric Vittinghoff, PhD |
Cardiovascular Disease, Women's Health |
|
|
Training pediatric cardiac surgeons in South East Asia |
Shunji Sano, MD, PhD |
Surgery and Anesthesia, Cardiovascular Disease, Training International Scholars and Clinicians |
|
|
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases |
Kirsten Bibbins-Domingo, MD, PhD |
Cardiovascular Disease, UCSF Professional Education |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program |
Ruth Greenblatt, MD |
HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education |
|
|
Understanding How Non-Adherence to Hypertension Medication Affects Utilization of GAIA Mobile Health Clinic Services in Mulanje, Malawi |
Anna Muller, MS |
Cardiovascular Disease, Treatment Adherence |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
VIPS: Vascular Effects of Infection in Pediatric Stroke |
Heather Fullerton, MD |
Cardiovascular Disease, Neurology and Mental Health, Pediatrics |
|
|
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Study |
|
Cardiovascular Disease |
|
|
ZERO AF Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation |
|
Cardiovascular Disease |
|
|